Asia-Pacific Blood Screening Market – Industry Trends and Forecast to 2027

  • In Vitro Diagnostics
  • Upcoming Report
  • Jun 2020
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Asia-Pacific Blood Screening Market By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Nucleic Acid Test, Enzyme-Linked Immunosorbent Assay, Rapid Tests, Western Blot Assay, Next-Generation Sequencing, Others), Disease Type (Respiratory Diseases, Diabetes Mellitus, Oncology, Cholesterol, HIV/AIDS, Cold & Flu, Infectious Diseases, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific) Industry Trends and Forecast to 2027

Asia-Pacific Blood Screening Market

Market Analysis and Insights: Asia-Pacific Blood Screening Market

Blood screening market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 0.85 billion by 2027 growing at a CAGR of 8.75% in the above-mentioned forecast period. The growing awareness amongst the patients regarding the donation of blood to a serious patient will help in driving the growth of the blood screening market.

The occurrences of new types of pathogens, increasing investment rates for advanced technology creation, growing geriatric population, and government’s favourable blood screening policies are likely to boost the growth of the blood screening market in the 2020-2027 forecast period. On the other hand, increasing healthcare sector along with raising technological innovation will further fuel numerous opportunities which will lead to blood screening market growth in the forecast period mentioned above. The high costs involved in sampling of blood will likely to hamper the growth of the blood screening market in the above mentioned forecast period.

This blood screening market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on blood screening market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific Blood Screening Market Scope and Market Size

Blood screening market is segmented on the basis of products & services, technology, disease type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product & services segment, the blood screening market is segmented into reagents and kits, instruments and software & services. Reagents and kits are further sub-segmented into NAT reagents & kits, ELISA reagents & kits others as well. NAT reagents is further sub-segmented into enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides and solutions also labelling and detection reagents. ELISA reagents & kits is further sub-segmented into immunosorbents, controls, conjugates (antigen or antibody-conjugated enzyme), substrates (of enzymes) also sample diluents and wash solutions. Instruments segment is further segmented into instruments, product types and instruments and purchase type.
  • On the basis of technology the blood screening market is segmented into nucleic acid test, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assay, next-generation sequencing (NGS) and others. Nucleic acid test is further sub-segmented into transcription-mediated amplification (TMA) and real-time polymerase chain reaction (PCR). Enzyme-linked immunosorbent assay (ELISA) is further segmented into ELISA market, by platform, ELISA market, by generation. ELISA Market, By Platform is further sub-segmented into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA) and colorimetric immunoassay (CI). ELISA market, by generation is further segmented into first-generation ELISA, second-generation ELISA, third-generation ELISA and fourth-generation and above.
  • On the basis of disease type segment, the blood screening market is segmented into respiratory diseases, diabetes mellitus, oncology, cholesterol, HIV/AIDS, cold & flu, infectious diseases and others.
  • The end user segment in the blood screening market is segmented into diagnostic centers, blood bank, hospitals, clinics and ambulatory surgical centers.

Blood Screening Market Country Level Analysis

Blood screening market is analysed and market size insights and trends are provided by country, products & services, technology, disease type and end user as referenced above.

The countries covered in the blood screening market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and Rest of Asia-Pacific (APAC).

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to rising patient affordability, increasing awareness among people about blood donation and growing focus of key industry players on emerging countries in the region. China, Japan, India, Singapore and Australia are major contributing countries in the Asia Pacific region.

The country section of the blood screening market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Blood Screening Market Share Analysis

Blood screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Blood Screening market.

The major players covered in the blood screening market report are Enzo Biochem Inc., Meridian Bioscience, Inc. , BD , Bio-Rad Laboratories, Inc. , Thermo Fisher Scientific Inc., BioMérieux SA, Beckman Coulter, Inc., Abbott , F. Hoffmann-La Roche Ltd , Cepheid , GRIFOLS INTERNATIONAL, S.A. , Siemens AG , Ortho Clinical Diagnostics , Immucor, Inc., Hologic Inc., among other domestic and Asia-Pacific players. Market share data is available for Asia-Pacific, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Asia-Pacific Blood Screening Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES ASIA-PACIFIC BLOOD SCREENING MARKET

TABLE 1 LIST OF PRICES FOR FEW DEVICES TABLE 2 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION) TABLE 3 ASIA-PACIFIC REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 4 ASIA-PACIFIC REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 5 ASIA-PACIFIC ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 6 ASIA-PACIFIC NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 7 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 8 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 9 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 10 ASIA-PACIFIC SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 11 ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 12 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 13 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 14 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION) TABLE 15 ASIA-PACIFIC RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 16 ASIA-PACIFIC NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 17 ASIA-PACIFIC NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 18 ASIA-PACIFIC NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 19 ASIA-PACIFIC WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 20 ASIA-PACIFIC OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 21 ASIA-PACIFIC BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 22 ASIA-PACIFIC ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 23 ASIA-PACIFIC DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 24 ASIA-PACIFIC COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 25 ASIA-PACIFIC CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 26 ASIA-PACIFIC INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 27 ASIA-PACIFIC RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 28 ASIA-PACIFIC HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 29 ASIA-PACIFIC OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 30 ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 31 ASIA-PACIFIC DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 32 ASIA-PACIFIC BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 33 ASIA-PACIFIC HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 34 ASIA-PACIFIC CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 35 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 36 ASIA-PACIFIC HOME HEALTHCARE MARKET, BY COUTRY, 2016-2025 (USD MILLION) TABLE 37 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 38 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 39 ASIA-PACIFIC ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 40 ASIA-PACIFIC NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 41 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 42 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 43 ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 44 ASIA-PACIFIC NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 45 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 46 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 47 ASIA-PACIFIC BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 48 ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 49 CHINA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 50 CHINA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 51 CHINA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 52 CHINA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 53 CHINA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 54 CHINA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 55 CHINA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 56 CHINA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 57 CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 58 CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 59 CHINA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 60 CHINA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 61 JAPAN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 62 JAPAN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 63 JAPAN ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 64 JAPAN NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 65 JAPAN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 66 JAPAN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 67 JAPAN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 68 JAPAN NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 69 JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 70 JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 71 JAPAN BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 72 JAPAN BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 73 SOUTH KOREA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 74 SOUTH KOREA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 75 SOUTH KOREA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 76 SOUTH KOREA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 77 SOUTH KOREA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 78 SOUTH KOREA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 79 SOUTH KOREA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 80 SOUTH KOREA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 81 SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 82 SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 83 SOUTH KOREA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 84 SOUTH KOREA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 85 INDIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 86 INDIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 87 INDIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 88 INDIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 89 INDIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 90 INDIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 91 INDIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)8 TABLE 92 INDIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 93 INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 94 INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 95 INDIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 96 INDIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 97 SINGAPORE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 98 SINGAPORE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 99 SINGAPORE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 100 SINGAPORE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 101 SINGAPORE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 102 SINGAPORE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 103 SINGAPORE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 104 SINGAPORE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 105 SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 106 SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 107 SINGAPORE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 108 SINGAPORE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 109 AUSTRALIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 110 AUSTRALIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 111 AUSTRALIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 112 AUSTRALIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 113 AUSTRALIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 114 AUSTRALIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 115 AUSTRALIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 116 AUSTRALIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 117 AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)3 TABLE 118 AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 119 AUSTRALIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 120 AUSTRALIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 121 THAILAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 122 THAILAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 123 THAILAND ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 124 THAILAND NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 125 THAILAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 126 THAILAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 127 THAILAND BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 128 THAILAND NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 129 THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 130 THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 131 THAILAND BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 132 THAILAND BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 133 MALAYSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 134 MALAYSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 135 MALAYSIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 136 MALAYSIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 137 MALAYSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 138 MALAYSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 139 MALAYSIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 140 MALAYSIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 141 MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 142 MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 143 MALAYSIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 144 MALAYSIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 145 INDONESIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 146 INDONESIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 147 INDONESIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 148 INDONESIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 149 INDONESIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 150 INDONESIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 151 INDONESIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 152 INDONESIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 153 INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 154 INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 155 INDONESIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 156 INDONESIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 157 PHILIPPINES BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 158 PHILIPPINES BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 159 PHILIPPINES ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 160 PHILIPPINES NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 161 PHILIPPINES INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 162 PHILIPPINES INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 163 PHILIPPINES BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 164 PHILIPPINES NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 165 PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 166 PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 167 PHILIPPINES BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 168 PHILIPPINES BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 169 REST OF ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19